Chair(s)
Prof Anita Wessels, North-West University, South AfricaIntroduction
The symposium will focus on the market and regulatory complexities of Cannabis products such as CBD oil. Ensuring quality products is essential in contributing to the safe and effective use of medicines.
Programme
13:00 – 13:05 |
Chair introduction |
13:05 – 13:25 |
Exploring the highs and laws: Navigating the landscape of Cannabinoid research and legislation |
13:25 – 13:45 |
On a high – What is in your CBD formulation |
13:45 – 13:55 | Q and A |
13:55 – 14:00 | Closing |
Learning objectives
- Identifying challenges in determining the quality of CBD oil and Cannabis products.
- Cannabis is a complex plant and therefore the analysis thereof is complex.
- Recognizing challenges in compliance with regulatory specifications for CBD oil.
- Providing insight into the Southern African perspective on the quality assurance of CBD oil.
Take home messages
The industry involving Cannabis related products such as Cannabidiol oil (CBD oil) derived from the Cannabis plant is young and evolving and in choosing a product, a supplier with high quality growing, processing and testing processes relating to the Cannabis plants and products, should be selected. There is still much to exploit regarding Cannabis products and their role as therapeutic pharmaceutical products. Laboratory testing will always be a key component.
A brief view of Cannabis products from the Lab to Legislation unveils the future of these products and the policies related to their use.